Зомепирак химические свойства, назначение, производство
Всемирная организация здравоохранения(ВОЗ)
Zomepirac, a nonsteroidal anti-inflammatory agent, was
introduced in 1979 for the treatment of rheumatic disorders and the management of
moderate to severe pain. By 1983 its use had been associated with serious allergic
reactions, including five deaths from anaphylaxis. This led to voluntary withdrawal
of the drug from markets worldwide by the major manufacturer.
Зомепирак препаратная продукция и сырье
сырьё
препарат